SWOT Analysis for Sai Life Science Ltd.

Benjamin Graham Value Screen
Relative Outperformance versus Industry over 1 Month
Growth Stars: Strongest Annual EPS Performers
Companies that saw improvement in net profits, operating profit margin and revenues in the most recent quarter
Expensive Performers (DVM)
Annual Profit Growth higher than Sector Profit Growth
Good quarterly growth in the recent results
Relative Outperformance versus Industry over 1 Month
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Companies with decreasing Promoter pledge
Stocks Outperforming their Industry Price Change in the Quarter

Companies that saw improvement in net profits, operating profit margin and revenues in the most recent quarter

Expensive Performers (DVM)

Annual Profit Growth higher than Sector Profit Growth

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Month

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Companies with decreasing Promoter pledge

Stocks Outperforming their Industry Price Change in the Quarter

Promoter decreasing their shareholding
MACD Crossover Below Signal Line
PE higher than Industry PE
High PE (PE > 40)
Oversold by Money Flow Index (MFI)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
Increasing Trend in Non-Core Income
RSI indicating price weakness
MACD crossed below signal line previous end of day
High promoter stock pledges
Top Losers

Promoter decreasing their shareholding

MACD Crossover Below Signal Line

PE higher than Industry PE

High PE (PE > 40)

Oversold by Money Flow Index (MFI)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

Increasing Trend in Non-Core Income

RSI indicating price weakness

MACD crossed below signal line previous end of day

High promoter stock pledges

Top Losers

Mutual Funds Increased Shareholding in Past Month
FII / FPI or Institutions increasing their shareholding
MFs increased their shareholding last quarter
Mutual Funds Increased Shareholding over the Past Two Months
Mf buying for 2 months

Mutual Funds Increased Shareholding in Past Month

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Big Changes up or down in FII holding
Expensive Performers (DVM)
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)

Big Changes up or down in FII holding

Expensive Performers (DVM)

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)

Sai Life Science Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Sai Life Science Ltd. has 16 Strengths, 12 Weaknesses, 5 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Benjamin Graham Value Screen

Relative Outperformance versus Industry over 1 Month

Growth Stars: Strongest Annual EPS Performers

Companies that saw improvement in net profits, operating profit margin and revenues in the most recent quarter

Expensive Performers (DVM)

Annual Profit Growth higher than Sector Profit Growth

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Month

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Companies with decreasing Promoter pledge

Stocks Outperforming their Industry Price Change in the Quarter

Promoter decreasing their shareholding

MACD Crossover Below Signal Line

PE higher than Industry PE

High PE (PE > 40)

Oversold by Money Flow Index (MFI)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

Increasing Trend in Non-Core Income

RSI indicating price weakness

MACD crossed below signal line previous end of day

High promoter stock pledges

Top Losers

Mutual Funds Increased Shareholding in Past Month

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Big Changes up or down in FII holding

Expensive Performers (DVM)

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)